3 news items
Qiming's Nisa Leung Made the 2024 Forbes Midas List
BILI
GPCR
SDGR
4 Jun 24
communication, research, financial advisory and business development. These services aim to bolster support to entrepreneurs and portfolio companies
Zai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO® (Sulbactam-Durlobactam or SUL-DUR) for Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Acinetobacter Baumannii-Calcoaceticus Complex in China
ZLAB
20 May 24
to shareholders; the status and timing of clinical studies, data analysis and communication of results; the potential benefits and mechanisms of action
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036
CRDF
JNJ
NTBL
9 May 24
that working with PanCAN will help to further enrich Oncolytics' clinical relationships with the pancreatic cancer community. We are also grateful
- Prev
- 1
- Next